Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
admin Eli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read MoreEli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge…
Read More